PHARMA LITERATI

The economic times reports about the possibility of large-scale CT exemption for Dengue vaccine.  As India reported a record number of dengue cases during the year, the health ministry is exploring the possibilities to accelerate the marketing authorisation for a preventive vaccine, health industry sources said. Dengvaxia , the brand name of the vaccine developed by Sanofi Pasteur, a unit of French pharmaceutical giant Sanofi, is being examined by the Indian drug regulatory agency for exemption from large-scale clinical trials on patients, the sources said. If cleared, the step may eventually pave the way for its availability via the wide government distribution system and private channels. Sanofi filed for the approval of the vaccine in India last month citing widespread prevalence and the high number of dengue cases seen in India, an industry source told ET. This month, Mexico's Federal Commission for the Protection against Sanitary Risks became the first drug regula...

The readers must have noticed sudden drop of blog-posts on Pharma Literati. The current bloggers are preoccupied with their professional activities. We @ pharma literati require bloggers for our blog. This is an opportunity to work with a team of passionate pharma professionals, students and faculties across India with lots of perks and benefits and learning opportunities.  This is a part time activity and the intellectuals need to put 3-4 hours a week as per the requirement from their own location.  As such, there is no remuneration available with the position. However, a certificate would be provided by team Pharma Literati. Please feel free to get in touch along with your CV to pharmaliterati@gmail.com Till the time new people join us there would be a break for the blog posts.  Team Pharma Literati  

The FDA has approved the first extended-release (ER) chewable tablet, developed by Tris Pharma. Prior ER tablets and capsules typically carried the warning “should not be chewed or crushed.” With other ER dosage forms, chewing or crushing can cause “dose dumping,” which can increase the concentration of a drug in the body, thereby producing adverse effects or even drug-induced toxicity. In clinical studies, the new ER chewable tablet technology released drug consistently, regardless of whether the tablet was chewed or swallowed whole. The ER chewable tablets are an extension of Tris Pharma’s LiquiXR platform , a particulate-based technology in which hundreds of millions of tiny (about 100 microns) particles deliver drug over time. Controlled release is facilitated by a flexible particle coating, which is why chewing does not compromise the release profile, according to Tris. The same particles can be used to formulate various oral ER dosage forms, such as liquid suspensions,...

2015 brought a plenty of significant steps forward in the field of health sowing seeds for major developments to unfold in 2016. From dengue virus ravaging Delhi to Ebola being declared an international health emergency, experts had to tackle a variety of medical challenges. Let's browse through some important ones:   Delhi in grip of worst dengue crisis since 1996 Delhi grappled with its worst dengue crisis in five years. Dengue is the most common mosquito-borne viral disease of humans that in recent years has become a major international public health concern. The number of cases almost touched 10, 000 this year. A breather came after a Bengaluru-based lab came up with a tablet to treat the dreaded vector-borne disease. The firm, Micro Labs Ltd launched a botanical pill 'Caripill' that helps to increase the platelet count in dengue patients. Also recently, the first-ever vaccine against dengue fever, which affects up to 400 million people per year, has...

Smt. Kishoritai Bhoyar College of Pharmacy (SKBCOP) organizes National Level Pharma-Quiz 2015-16. Last date to register:       Dec 20th, Sunday. Registration fees:              200 Rs.  Prelims (Online):                Dec 27th, 2015, Sunday, 10 AM to 11 AM. Semi-finals and Finals:    Dr. Vasantrao deshpande hall, Civil lines, Nagpur. Feb 2nd, 2016. Quiz Structure PRELIMINARY ROUND Preliminary screening will be done through online exam. Each team will be provided ONE log-in id and password via e-mail. Group of 2 students in a team has to attempt the Preliminary round with single log-in. If log-in was done in multiple systems, their account will be automatically blocked. So please don’t share your log-in details with any other person outside your team. Preliminary round pattern: Rapid fire type objective questions; each question will be displayed fo...